Co Wicklow students learn how to get a head for world of business
Bray People
The students of St Peter's NS, Bray, took part in a real-life, immersive entrepreneurship skills programme for primary school children, called the Junior Entrepreneur Programme recently – a bit like Dragons' Den but without the dragons.
The programme aims to nurture confidence, resilience, creativity, problem-solving and teamwork and engages pupils of all abilities.
The project was for the fifth class students, who worked in four teams and had to envisage and develop a business idea for scratch.
The winning team was Bandana Boutique, a pet and toy bandana business. And once the winning idea was chosen, the whole class got involved to work together to make the business as successful as possible, collaborating on design and production, finance, marketing, sales and communications.
The students made different size bandanas from donated material, which have a reflective feature for safety on the front and can be easily slid on to dog/cat collars.
They will donate 10pc of the proceeds to a dog charity.
They also made posters, conducted market research, and advertised and promoted their product around the school.
The big showcase days were on Thursday and Friday, May 1 and 2, and there was a terrific buzz in the school when family and friends came along to their pop-up shop, learn more about their JEP journey and of course, buy some bandanas.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
5 minutes ago
- Yahoo
Kendrick Lamar's ‘GNX' Wins Album of The Year at The 2025 BET Awards
Kendrick Lamar took home the award for Album of the Year at the 2025 BET Awards, beating out Beyoncé, The Weeknd, Drake, and more, and adding to the impressive string of accolades for the L.A. rapper following his now-infamous feud with Drake. His award was presented to him by actor Keke Palmer. During his acceptance speech, he acknowledged that he hasn't often attended the BET Awards in recent years, but said it's always been important to him. 'I ain't been here in a long time,' he said, 'BET always makes sure that they represent the culture right, and always put me in the midst of the cycle of what we represent, and that's real, true down to Earth music that people can feel. So I always give my heart to BET.' He looked towards the back of the crowd and showed out 'All my L.A. natives' before thanking God and his company, PG Lang. More from Rolling Stone Teyana Taylor Makes the BET Awards Her 'Escape Room' in Fiery Performance Lil Wayne Wows the BET Awards With 'A Milli' Performance Doechii Slams Trump's L.A. Protest Crackdown While Accepting BET Award He also shouted out SZA, who was also in attendance and added, 'We on tour right now, please come to the show.' They are in fact in the middle of their Grand National tour, which finishes its North American dates this month and hits Europe in July. Lamar, who is the night's most nominated act, was handed a slew of additional trophies by host Kevin Hart, though the particulars of the awards were not named. Best of Rolling Stone Sly and the Family Stone: 20 Essential Songs The 50 Greatest Eminem Songs All 274 of Taylor Swift's Songs, Ranked
Black America Web
5 minutes ago
- Black America Web
Sly Stone's Music Formed The Backdrop To Several Hip-Hop Classics
Sly Stone, a legendary musician who helped propel funk to its elevated heights in the realm of Black music, has died. Hip-Hop artists of various eras have sampled Sly Stone's work over the years, and we've got a playlist highlighting some of those audio classics. As Hip-Hop Wired reported earlier, Sly Stone, born Sylvester Stewart in Denton, Texas, passed away Monday (June 9) at the age of 82. After establishing his roots in the Bay Area as a musical prodigy, Stone ventured into becoming a front-facing artist with his Sly and The Stones in the 1960s with the late Cynthia Robinson, the trumpeter who was a founding member of Sly and the Family Stone, the band that catapulted Stone into the annals of music history. Alongside fun pioneers such asJames Brown and Parliament-Funkadelic, Stone and his band enjoyed a successful run of album releases extending into the late 1970s. Stone's life was captured in the 2023 biography, Thank You (Falettinme Be Mice Elf Agin), written with Ben Greenman, featuring a foreword from Ahmir 'Questlove' Thompson. Thompson also produced the stirring 2025 documentary centered on Stone's life and legacy, Sly Lives! (aka the Burden of Black Genius) . Hip-Hop artists such as LL Cool J, Queen Latifah, The Jungle Brothers, Public Enemy, and scores more dug into the crates to grab bits of Stone's music to form the backdrop of their works. Below, we've got a handful of those songs featured in the playlist below. Long live Sly Stone. May he rest powerfully in peace. — Photo: Michael Putland / Getty Sly Stone's Music Formed The Backdrop To Several Hip-Hop Classics was originally published on Samples 'Trip To Your Heart.' Samples 'Dance to the Music.' Samples 'You Can Make It If You Try.' Samples 'Sing A Simple Song.' Samples 'Everyday People.' Black America Web Featured Video CLOSE
Yahoo
5 minutes ago
- Yahoo
AriBio and Arcera Sign Exclusive Licensing and Supply Agreements for Investigational Drug for Alzheimer's Disease
Seongnam-si, South Korea and Abu Dhabi, UAE, June 09, 2025 (GLOBE NEWSWIRE) -- AriBio Co., Ltd. ("AriBio"), a South Korean biopharmaceutical company specializing in neurodegenerative diseases, and a Swiss pharmaceutical company Acino, part of Arcera, a global life sciences company based in Abu Dhabi (collectively 'Arcera'), today announced the signing of exclusive licensing and commercialization, and supply agreements for AR1001, an investigational oral therapy for Alzheimer's disease. Under the terms of the agreements, Arcera will have exclusive rights to commercialize AR1001 in its key markets, including Latin America, the Middle East, Southern Africa, Ukraine and select Eurasian countries. AriBio will be responsible for manufacturing and supplying the product. The total deal value is estimated at USD 600 million across the development, launch and commercialization period, contingent upon the achievement of certain milestones. AR1001 is a novel, disease-modifying, once-daily oral phosphodiesterase-5 (PDE5) inhibitor currently being studied in a global Phase 3 clinical trial (POLARIS-AD) for the treatment of early-stage Alzheimer's disease. The enrollment target for the Phase 3 trial has been reached, and the topline results are expected in the first half of 2026. Facilitated by the Korea Development Bank (KDB) and aligned with the Korean government's policy to foster the biohealth industry, this collaboration represents a significant step forward to enhance the global competitiveness of Korea's pharmaceutical and biotech industry. "This partnership with Arcera marks a significant milestone in our mission to bring innovative treatments to patients worldwide," said Jai Jun Choung, CEO of AriBio. "Arcera's strong commercial capabilities and deep understanding of the high-growth markets make them an ideal partner to advance AR1001 in these important regions." "We are excited to enter into this collaboration with AriBio, which will provide access to AR1001, a novel treatment, for patients across these countries," said Isabel Afonso, CEO of Arcera. "This agreement aligns with our strategy to expand our neuroscience portfolio and reinforces our commitment to providing access to novel therapies in regions with significant unmet medical needs." The agreement underscores both companies' dedication to addressing unmet medical needs in neurodegenerative diseases and enhancing patient access to innovative therapies globally. This deal follows the Memorandum of Understanding signed between AriBio and Arcera in March 2025, where both parties agreed to strengthen their partnership by actively exploring strategic investments, and advancing joint research and development based on shared interests. ENDS About AriBio Co., Ltd. Founded in 2010, AriBio is a clinical-stage biopharmaceutical company headquartered in South Korea, with offices located in the United States to manage global clinical operations and regulatory affairs. The company focuses on the development of novel therapies for neurodegenerative diseases, including Alzheimer's disease. AriBio continues to expand its partnerships to accelerate the development and delivery of life-changing treatments to patients worldwide. About Arcera Arcera is a global life sciences company, headquartered in Abu Dhabi. Arcera develops, manufactures, and commercializes a broad range of high-quality proven and innovative medicines in key international markets. Its portfolio exceeds 2,000 medicines covering wide therapeutic areas which reach patients in ninety countries in four continents, backed by manufacturing and packing sites across the world. Arcera was established by the sovereign wealth fund, ADQ to realize Abu Dhabi's ambition as a global leader in innovative and sustainable healthcare. To learn more about Arcera, visit Attachment AriBio and Arcera Sign Exclusive Licensing and Supply Agreements for Investigational Drug for Alzheimer's Disease CONTACT: Tanya Xi, MD, PhD, MBA, Senior Director, Business Development & Medical Affairs, AriBio (US) AriBio Co., Ltd. tanyaxi@ Rafael Ferrer, SVP Corporate Development. Arcera rferrer@ in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
